Patent Assignment
Reel/Frame 039857/0661
Assignment of Assignor's Interest
Recorded: 2016-09-26
Pages: 12
Assignor
ACTAVIS LABORATORIES UT, INC.
Executed: 2015-12-31
Assignee
ALLERGAN SALES, LLC
2525 DUPONT DR., IRVINE, CALIFORNIA, 92612
Covered Properties
(37)
Triacetin as a Penetration Enhancer for Transdermal Delivery of a Basic Drug
Patent:
5,601,839 →
Application:
08/429,757 →
Drug Delivery Compositions for Improved Stability of Steroids
Patent:
5,780,050 →
Application:
08/504,430 →
Compositions and Methods for Buccal Delivery of Pharmaceutical Agents
Patent:
5,849,322 →
Application:
08/546,994 →
Pressure Sensitive Adhesive Matrix Patches for Transdermal Delivery of Salts of Pharmaceutical Agents
Patent:
5,985,317 →
Application:
08/706,624 →
Triacetin as a Penetration Enhancer for Transdermal Delivery of a Basic Drug
Patent:
5,834,010 →
Application:
08/775,367 →
Fatty Acid Esters of Glycolic Acid and Its Salts
Patent:
5,912,009 →
Application:
08/959,944 →
Fatty Acid Esters of Lactic Acid Salts as Permeation Enhancers
Patent:
5,952,000 →
Application:
08/959,946 →
Buccal Delivery of Glucagon-Like Insulinotropic Peptides
Patent:
5,863,555 →
Application:
08/964,731 →
Compositions and Methods for Minimizing Adverse Drug Experiences Associated with Oxybutynin Therapy
Compositions and Methods for Transdermal Oxybutynin Therapy
Compositions and Methods for Minimizing Adverse Drug Experiences Associated with Oxybutynin Therapy
Compositions and Methods for Minimizing Adverse Drug Experiences Associated with Oxybutynin Therapy
Compositions and Methods for Minimizing Adverse Drug Experiences Associated with Oxybutynin Therapy
Compositions and Methods for Minimizing Adverse Drug Experiences Associated with Oxybutynin Therapy
Compositions and Methods for Transdermal Oxybutynin Therapy
Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
Compositions and Methods for Minimizing Adverse Drug Experiences Associated with Oxybutynin Therapy
Medicament Dispenser and Associated Methods
Unoccluded Topical Oxybutynin Gel Composition and Methods for Transdermal Oxybutynin Therapy
Peelable Pouch for Transdermal Patch and Method for Packaging
Patent:
7,921,999 →
Application:
11/645,115 →
Frangible Shipping Carton and Associated Methods
Progesterone for the Treatment or Prevention of Spontaneous Preterm Birth
Compositions and Methods for Transdermal Oxybutynin Therapy
Application:
12/236,585 →
Publication:
US 2009/0018190
Method for Treating Overactive Bladders and a Device for Storage and Administration of Topical Oxybutynin Compositions
Progesterone for the Treatment or Prevention of Spontaneous Preterm Birth
Frangible Shipping Carton and Associated Methods
Peelable Pouch for Transdermal Patch and Method for Packaging
Peelable Pouch for Transdermal Patch and Method for Packaging
Medicament Dispenser and Associated Methods
High Dosage Mucoadhesive Metronidazole Aqueous-Based Gel Formulations and Their Use to Treat Bacterial Vaginosis
Methods of Treating Bacterial Vaginosis with Aqueous-Based Metronidazole Gel Formulations
Method for Treating Overactive Bladders and a Device for Storage and Administration of Topical Oxybutynin Compositions
Peelable Pouch for Transdermal Patch and Method for Packaging
Aqueous-Based Metronidazole Gel Formulations
Frangible Shipping Carton and Associated Methods
Progesterone for the Treatment or Prevention of Spontaneous Preterm Birth
Application:
60/888,480 →
Progesterone for the Treatment or Prevention of Spontaneous Preterm Birth
Application:
60/973,667 →
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 18, 2004
From: SANDERS, STEVEN W.; EBERT, CHARLES D.
To: WATSON PHARMACEUTICALS, INC.
Reel/Frame 016007/0261 →
Assignment of Assignor's Interest
Nov 18, 2005
From: EBERT, CHARLES; HOEL, GARY; ANIGBOGU, ANGELA; ROY, SAMIR
To: WATSON LABORATORIES, INC.
Reel/Frame 017245/0013 →
Assignment of Assignor's Interest
Jan 12, 2006
From: WATSON PHARMACEUTICALS, INC.
To: WATSON LABORATORIES, INC.
Reel/Frame 017008/0159 →
Assignment of Assignor's Interest
Mar 21, 2006
From: BITNER, JOHN
To: WATSON LABORATORIES, INC.
Reel/Frame 017677/0908 →
Assignment of Assignor's Interest
Apr 28, 2006
From: WATSON PHARMACEUTICALS, INC.
To: WATSON LABORATORIES, INC.
Reel/Frame 017550/0642 →
Assignment of Assignor's Interest
Apr 28, 2006
From: WATSON PHARMACEUTICALS, INC.
To: WATSON LABORATORIES, INC.
Reel/Frame 017544/0344 →
Assignment of Assignor's Interest
Apr 28, 2006
From: WATSON PHARMACEUTICALS, INC.
To: WATSON LABORATORIES, INC.
Reel/Frame 017544/0454 →
Assignment of Assignor's Interest
Apr 28, 2006
From: WATSON PHARMACEUTICALS, INC.
To: WATSON LABORATORIES, INC.
Reel/Frame 017544/0468 →
Assignment of Assignor's Interest
Apr 28, 2006
From: WATSON PHARMACEUTICALS, INC.
To: WATSON LABORATORIES, INC.
Reel/Frame 017544/0637 →
Assignment of Assignor's Interest
Jun 14, 2006
From: SANDERS, STEVEN W.; EBERT, CHARLES D.
To: WATSON PHARMACEUTICALS, INC.
Reel/Frame 017776/0417 →
Assignment of Assignor's Interest
Aug 28, 2006
From: WATSON PHARMACEUTICALS, INC.
To: WATSON LABORATORIES, INC.
Reel/Frame 018171/0872 →
Assignment of Assignor's Interest
Jan 25, 2007
From: KIMBALL, MICHAEL W.
To: WATSON LABORATORIES, INC.
Reel/Frame 018803/0756 →
Assignment of Assignor's Interest
Oct 21, 2008
From: WATSON PHARMACEUTICALS, INC.
To: WATSON LABORATORIES, INC.
Reel/Frame 021709/0645 →
Assignment of Assignor's Interest
Oct 21, 2008
From: THERATECH, INC.
To: WATSON LABORATORIES, INC.
Reel/Frame 021709/0640 →
Assignment of Assignor's Interest
Jun 28, 2012
From: WATSON PHARMACEUTICALS, INC.
To: WATSON LABORATORIES, INC.
Reel/Frame 028458/0886 →
Change of Name
Mar 4, 2015
From: WATSON LABORATORIES, INC.
To: ACTAVIS LABORATORIES UT, INC.
Reel/Frame 035127/0305 →
Change of Name
May 5, 2016
From: WATSON LABORATORIES, INC.
To: ACTAVIS LABORATORIES UT, INC.
Reel/Frame 038612/0272 →